Utilidad de la monitorización terapéutica de infliximab en el manejo de la enfermedad inflamatoria intestinal

Background: Primary non-response and secondary loss of response (LOR) are significant problems of biological therapy for inflammatory bowel disease (IBD). Therapeutic drug monitoring (TDM) in IBD patients receiving these drugs can improve outcomes. Aim: To measure serum infliximab levels and anti-...

Full description

Saved in:
Bibliographic Details
Main Authors: Quera,Rodrigo, Moreno,Mauricio, Simian,Daniela, Ibáñez,Patricio, Lubascher,Jaime, Figueroa,Carolina, Flores,Lilian, Kronberg,Udo, Pizarro,Gonzalo, Fluxá,Daniela
Language:Spanish / Castilian
Published: Sociedad Médica de Santiago 2018
Subjects:
Online Access:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872018001101241
Tags: Add Tag
No Tags, Be the first to tag this record!